drugset / Trial / NCT00957983
EP4-receptor Antagonism and Prostaglandin E2 (PGE2) in a Human Headache Model
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this study is to determine whether EP-4 receptor antagonist can prevent the headache expected during a Prostaglandin E2 infusion.
Timeline
- Start
- 2009-08
- Primary completion
- 2010-02
- Completion
- 2010-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | BGC20-1531 | Small molecule | 200 mg | Oral |
| Comparator | BGC20-1531 | Small molecule | 400 mg | Oral |